Recently Added
ID:
Company:
sector:
industry:
industry_subclass:
usSymbol:
commonSymbol:
Warrant:
rtSymbol:
cusip:
filingLink:
underlyingDocument:
warrantTerms:
expiry:
exercise:
country:
sec_cik:
sedar_ref:
exchange:
phone:
address:
longitude:
latitude:
description:
targetCountry:
logo_src:
notes:
warrant_clause:
insiders:
commonChart:
RATING:
website:
warrantATH:
warrantATL:
project:
property:
prop_lon:
prop_lat:
prop_type:
prop_details:
front_adj_common:
front_adj_wt:
front_adj_rt:
chart_c:
chart_w:
chart_r:
cdate:
copen:
chigh:
clow:
cclose:
cvolume:
wdate:
wopen:
whigh:
wlow:
Close:
wvolume:
rdate:
ropen:
rhigh:
rlow:
rclose:
rvolume:
cpctchg:
wpctchg:
rpctchg:
Intrinsic:
Most Active
| ID | Company | sector | industry | industry_subclass | usSymbol | commonSymbol | Warrant | rtSymbol | cusip | filingLink | underlyingDocument | warrantTerms | expiry | exercise | country | sec_cik | sedar_ref | exchange | phone | address | longitude | latitude | description | targetCountry | logo_src | notes | warrant_clause | insiders | commonChart | RATING | website | warrantATH | warrantATL | project | property | prop_lon | prop_lat | prop_type | prop_details | front_adj_common | front_adj_wt | front_adj_rt | chart_c | chart_w | chart_r | cdate | copen | chigh | clow | cclose | cvolume | wdate | wopen | whigh | wlow | Close | Volume | rdate | ropen | rhigh | rlow | rclose | rvolume | cpctchg | wpctchg | rpctchg | Intrinsic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9221 | MSP Recovery, Inc. | HEALTHCARE, CONSUMER, TECHNOLOGY | Healthcare | Medicare, Medicaid, commercial, and secondary payer reimbursement recovery | NULL | MSPR | MSPRW | NULL | NULL | 1 wt:1 sh | 2027-05-24 | 11.5000 | US | 1,802,450 | NULL | OTC | 305.614.2222 | 3150 SW 38TH AVENUE, SUITE 1100, MIAMI, FL, 33146 | -80.1916604 | 25.8153609 | Lionheart Acquisition Corp II operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. |  |
Merger Completed on Tuesday, 05/24/2022 | Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment as described herein. Warrants may be exercised only for a whole number of shares of Class A common stock. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination or 12 months from the closing of this offering, and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation, as described in this prospectus. | https://stockhouse.com/companies/quote?symbol=MSPR | Coming Soon | 0.0047 | 0.0002 | NULL | NULL | NULL | NULL | NULL | NULL | LIFW | LIFWZ | NULL | MSPR | MSPRW | NULL | 2026-02-04 12:00 AM | 0.045 | 0.05 | 0.031 | 0.0400 | 106,259 | 2026-02-04 12:00 AM | 0.0005 | 0.0006 | 0.0003 | 0.00 | 3,283,579 | -18.367346938775512 | -40.00000000000001 | -11.46 | ||||||||||||
| 330 | Advent Technologies | FUEL CELL | Energy | Fuel cell and hydrogen technology | NULL | ADN | ADNWW | NULL | NULL | 1 wt:1 sh | 2026-02-05 | 11.5000 | US | 1,744,494 | NULL | None | 857-264-7035 | 500 RUTHERFORD AVENUE, SUITE 102, BOSTON, MA, 02129 | -71.075124 | 42.3491676 | Advent Technologies’ mission is to become the leading provider of high-temperature proton exchange membranes (“HT-PEM”) and HT-PEM based membrane electrode assemblies (“MEA”), which are critical components used in fuel cells, and other electrochemistry applications such as electrolyzers, flow batteries, and IoT sensors. Advent’s principal focus is on the fuel cell market, and Advent’s goal is to use its products and technology to address pressing global climate needs. In order to meet the targets established in the Paris Climate Accord, which seek to mitigate climate change and maintain global temperature less than 1.5-2.0°C above pre-industrial levels, the global community will need to hasten adoption of technologies that reduce or eliminate emissions of carbon-dioxide and other greenhouse gasses. |  |
Merger Completed on Friday, 02/05/2021 | Each unit has an offering price of? $10.00 and consists of one share of our Class A common stock and one redeemable warrant. Each warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of? $11.50 per share, subject to adjustment as described herein. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination or 12 months from the closing of this offering, and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation | https://stockhouse.com/companies/quote?symbol=ADN | Undervalued | 0.0249 | 0.0001 | NULL | NULL | NULL | NULL | NULL | NULL | ADN | ADNWW | NULL | ADN | ADNWW | NULL | 2025-10-29 12:00 AM | 1.16 | 1.39 | 0.9 | 0.9185 | 4,602,306 | 2026-02-02 12:00 AM | 0.0003 | 0.0004 | 0.0001 | 0.00 | 1,898,550 | 0 | 0 | -10.58 | ||||||||||||
| 14042 | USA Rare Earth, Inc. | MINING | MINING | domestic supplier of rare earth neo magnets and heavy rare earths | NULL | USAR | USARW | NULL | NULL | 1 wt:1 sh | 2030-03-13 | 11.5000 | US | 1,970,622 | NULL | Nasdaq | 813-867-6155 | 100 W AIRPORT ROAD, STILLWATER, OK, 74075 | Inflection Point Acquisition Corp. II’s acquisition and value creation strategy is to identify, partner with and help grow North American and European businesses in disruptive growth sectors, which complements the expertise of its management team. However, the Company may pursue an initial business combination in any industry, sector or geographic region. |  |
NULL | Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “IPXX” and “IPXXW,” respectively. | https://stockhouse.com/companies/quote?symbol=USAR | Coming Soon | 27.3500 | 0.6701 | IPXX | IPXXW | NULL | USAR | USARW | NULL | 2026-02-04 12:00 AM | 26.09 | 26.2 | 22.065 | 23.5300 | 34,297,102 | 2025-12-01 12:00 AM | 1.94 | 1.94 | 1.07 | 1.10 | 1,371,552 | -9.395456295725829 | 0 | 12.03 | ||||||||||||||||||||
| 13147 | Launch One Acquisition Corp. Warrant | SPAC | NULL | LPAA | LPAAW | NULL | NULL | 1 wt:1 sh | 2026-07-11 | 11.5000 | US | 2,015,502 | NULL | Nasdaq | 5106929600 | 180 GRAND AVENUE SUITE 1530, OAKLAND, CA, 94612 | Launch One Acquisition Corp.is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination in any business or industry. |  |
NULL | Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as described herein. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The warrants will become exercisable 30 days after the completion of our initial business combination, and will expire five years after the completion of our initial business combination or earlier upon redemption or our liquidation, as described herein. The underwriters have a 45-day option from the date of this prospectus to purchase up to an additional 3,000,000 units to cover over-allotments, if any. | https://stockhouse.com/companies/quote?symbol=LPAA | Coming Soon | 0.3100 | 0.1101 | LPAA | LPAAW | NULL | 2026-02-04 12:00 AM | 10.7 | 10.7 | 10.64 | 10.6400 | 26,811 | 2026-02-04 12:00 AM | 0.15 | 0.15 | 0.1064 | 0.11 | 1,081,068 | 0 | -44.922461230615305 | -0.86 | |||||||||||||||||||||||||
| 15534 | GameStop Corp. Warrants to Purchase Common Stock | GME.WS | US | 1,326,380 | NULL | NYSE | 817-424-2000 | 625 WESTPORT PARKWAY, GRAPEVINE, TX, 76051 |  |
4.3800 | 2.55 | 2026-02-04 12:00 AM | 4.27 | 4.36 | 4.06 | 4.24 | 990,893 | 0.7125890736342102 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 15558 | Opendoor Technologies Inc Series Z Warrants, each whole warrant exercisable to purchase one share of Common Stock at an exercise price of $17.00 per warrant | OPENZ | US | 1,801,169 | NULL | Nasdaq | 480-618-6760 | 410 N. SCOTTSDALE ROAD, SUITE 1000, TEMPE, AZ, 85288 |  |
1.0600 | 0.3684 | 2026-02-04 12:00 AM | 0.4018 | 0.4051 | 0.34 | 0.37 | 990,508 | -3.2191069574247058 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 13228 | SIM Acquisition Corp. I | SPAC | NULL | SIMA | SIMAW | NULL | NULL | 1 wt:1 sh | 2026-07-09 | 11.5000 | US | 2,014,982 | NULL | Nasdaq | 2039402657 | 78 SW 7TH STREET, SUITE 500, MIAMI, FL, 33130 | SIM Acquisition Corp. I is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination in any business or industry but expect to focus on companies in the healthcare industry. |  |
NULL | Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as described herein. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The warrants will become exercisable 30 days after the completion of our initial business combination, and will expire five years after the completion of our initial business combination or earlier upon redemption or our liquidation, as described herein. The underwriters have a 45-day option from the date of this prospectus to purchase up to an additional 3,000,000 units to cover over-allotments, if any. | https://stockhouse.com/companies/quote?symbol=SIMA | Coming Soon | 0.4196 | 0.1014 | SIMA | SIMAW | NULL | 2026-02-04 12:00 AM | 10.68 | 10.68 | 10.68 | 10.6800 | 432 | 2026-02-04 12:00 AM | 0.422 | 0.44 | 0.4 | 0.42 | 929,006 | 0.3287928604978877 | 44.689655172413794 | -0.82 | |||||||||||||||||||||||||
| 15533 | GLOBALINK INVESTMENT | GLLIW | US | NULL |  |
0.1000 | 0.0067 | 2025-10-30 12:00 AM | 0.09 | 0.13 | 0.071 | 0.10 | 813,971 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 9452 | LakeShore Biopharma Co., Ltd | HEALTHCARE | BioPharma | Advancing novel immunotherapeutics to treat infectious disease and cancer | NULL | LSBP | LSBPW | NULL | NULL | 1 wt:1 sh | 2028-03-17 | 11.5000 | US | 1,839,185 | NULL | NSDQ | 212-446-4800 | UGLAND HOUSE, BOX 309, GRAND CAYMAN, E9, KY1-1104 | 114.1539255 | 22.2825133 | YS Biopharma is a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. | |
Merger Completed on Friday, 03/17/2023 | Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment, terms and limitations as described herein. | https://stockhouse.com/companies/quote?symbol=LSBP | Undervalued | 0.0820 | 0.0102 | NULL | NULL | NULL | NULL | NULL | NULL | YS | YSBPW | NULL | LSBP | LSBPW | NULL | 2025-09-19 12:00 AM | 0.0151 | 0.0219 | 0.0101 | 0.01 | 772,863 | 0 | ||||||||||||||||||||
| 8785 | Direct Selling Acquisition Corp. | SALES, CONSUMER, RETAIL | SPAC | we intend to capitalize on our management team’s significant knowledge of the healthcare landscape and proven ability to source, acquire and manage a business in the healthcare industry | NULL | DSAQ | DSAQW | NULL | NULL | 1 wt:1 sh | 2022-12-24 | 11.5000 | US | 1,871,745 | NULL | NYSE | 2143086020 | 5800 DEMOCRACY DRIVE, PLANO, TX, 75024 | -96.822668 | 33.068359 | Direct Selling Acquisition Corp. is a blank check company whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. |  |
NULL | Each unit has an offering price of $10.00 and consists of one share of Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of Class A common stock at a price of $11.50 per share, subject to adjustment as described herein. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination and 12 months from the closing of this offering, and will expire five years after the completion of our initial business combination or earlier upon redemption or our liquidation, as described herein | https://stockhouse.com/companies/quote?symbol=DSAQ | Coming Soon | 0.0800 | 0.0004 | NULL | NULL | NULL | NULL | NULL | NULL | DSAQ | DSAQW | NULL | DSAQ | DSAQW | NULL | 2025-06-17 12:00 AM | 11.69 | 11.69 | 11.69 | 11.6900 | 1 | 2025-12-23 12:00 AM | 0.0001 | 0.0004 | 0.0001 | 0.00 | 732,211 | 0 | 0 | 0.19 |
ID:
Company:
sector:
industry:
industry_subclass:
usSymbol:
commonSymbol:
Warrant:
rtSymbol:
cusip:
filingLink:
underlyingDocument:
warrantTerms:
expiry:
exercise:
country:
sec_cik:
sedar_ref:
exchange:
phone:
address:
longitude:
latitude:
description:
targetCountry:
logo_src:
notes:
warrant_clause:
insiders:
commonChart:
RATING:
website:
warrantATH:
warrantATL:
project:
property:
prop_lon:
prop_lat:
prop_type:
prop_details:
front_adj_common:
front_adj_wt:
front_adj_rt:
chart_c:
chart_w:
chart_r:
cdate:
copen:
chigh:
clow:
cclose:
cvolume:
wdate:
wopen:
whigh:
wlow:
Close:
Volume:
rdate:
ropen:
rhigh:
rlow:
rclose:
rvolume:
cpctchg:
wpctchg:
rpctchg:
Intrinsic:
Gainers
| ID | Company | sector | industry | industry_subclass | usSymbol | commonSymbol | Warrant | rtSymbol | cusip | filingLink | underlyingDocument | warrantTerms | expiry | exercise | country | sec_cik | sedar_ref | exchange | phone | address | longitude | latitude | description | targetCountry | logo_src | notes | warrant_clause | insiders | commonChart | RATING | Website | warrantATH | warrantATL | project | property | prop_lon | prop_lat | prop_type | prop_details | front_adj_common | front_adj_wt | front_adj_rt | chart_c | chart_w | chart_r | cdate | copen | chigh | clow | cclose | cvolume | wdate | wopen | whigh | wlow | Wt Close | Wt Volume | rdate | ropen | rhigh | rlow | rclose | rvolume | cpctchg | Wt PCT CHG | rpctchg | Intrinsic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6181 | Expand Energy Corporation Class A Warrants | OIL & GAS | Energy | Oil & Gas | NULL | EXE | EXEEW | NULL | NULL | 1 wt:1 sh | 2026-02-09 | 27.6300 | US | 895,126 | NULL | Nasdaq | 4058488000 | 6100 N WESTERN AVE, OKLAHOMA CITY, OK, 73118 | -97.5288582 | 35.5345386 | Chesapeake Energy Corp is a US-based exploration and production company. It is engaged in the acquisition, exploration, and development of properties for the production of oil, natural gas and natural gas liquids from underground reservoirs. Geographically, the company focuses its exploration, development, acquisition and production efforts in the operating areas of Marcellus, Northern Appalachian Basin in Pennsylvania; Haynesville, Northwestern Louisiana and East Texas (Gulf Coast); Eagle Ford, South Texas; Utica, Southern Appalachian Basin in Ohio; Mid-Continent, Anadarko Basin in northwestern Oklahoma; and Powder River Basin, Stacked pay in Wyoming. | |
NULL | “Exercise Price” means $27.63, subject to adjustment as provided in Article 4. “Expiration Time” means the earlier of (i) the Close of Business on February 9, 2026 and (ii) the date of consummation of any Liquidity Event. | https://stockhouse.com/companies/quote?symbol=EXE | Coming Soon | 125.0000 | 0.0101 | NULL | NULL | NULL | NULL | NULL | NULL | CHK | CHKEW | NULL | EXE | EXEEW | NULL | 2026-02-04 12:00 AM | 110.11 | 110.63 | 107.385 | 109.1900 | 2,259,581 | 2026-02-04 12:00 AM | 70 | 138.56 | 70 | 125.000 | 2,959 | 0.6359447004608274 | 1,237,523.76 | 81.56 | ||||||||||||
| 14019 | Crown LNG | NULL | CGBSF | CGBWF | NULL | NULL | 1 wt:1 sh | 2029-07-09 | 11.5000 | US | 1,838,293 | NULL | NYSE | 65-63252788 | 3 RAFFLES PLACE #06-01, BHARAT BUILDING, SINGAPORE, U0, 048617 | 101.6942371 | 3.1516964 | Catcha Investment Corp is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We will not be limited to a particular industry or geographic region in our identification and acquisition of a target company. |  |
Merger Completed on Tuesday, 07/09/2024 | Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at $11.50 per share, subject to adjustment, terms and limitations as described herein. | https://stockhouse.com/companies/quote?symbol=CGBSF | Coming Soon | 0.0298 | 0.000001 | NULL | NULL | NULL | NULL | NULL | NULL | CHAA | CHAAW | NULL | CGBSF | CGBWF | NULL | 2026-02-04 12:00 AM | 0.0001 | 0.0001 | 0.0001 | 0.0001 | 125,101 | 2026-02-04 12:00 AM | 0.001 | 0.001 | 0.001 | 0.001 | 333 | 0 | 99,900.00 | -11.50 | |||||||||||||||
| 6664 | Ensysce Biosciences, Inc. | BIOPHARMA | Biopharma | Biopharmaceutical company | NULL | ENSC | ENSCW | NULL | NULL | 1 wt:1 sh | 2026-06-28 | 11.5000 | US | 1,716,947 | NULL | Nasdaq | (858) 263-4196 | 7946 IVANHOE AVENUE, SUITE 201, LA JOLLA, CA, 92037 | -117.2723958 | 32.848542 | Ensysce Biosciences, Inc. is a clinical stage pharmaceutical company developing innovative solutions for severe pain relief while reducing the fear of and the potential for addiction, opioid misuse, abuse and overdose. Our current development pipeline includes two new drug platforms - an abuse-resistant opioid prodrug technology – the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology - the Multi-Pill Abuse Resistant, or the MPAR™ platform. The TAAP platform is designed to improve the care of patients with chronic pain while reducing the human and economic costs associated with prescription opioid drug abuse. The MPAR™ platform when combined with our TAAP prodrugs is designed not only to prevent abuse of prescription drugs but also to reduce overdose occurrences. Additionally, nafamostat di-mesylate, which is an ingredient in our overdose protection combination products, is also being developed for the intended purpose of treating infection and pulmonary lung diseases. |  |
Merger Completed on Monday, 06/28/2021 | Each unit has an offering price of $10.00 and consists of one share of our common stock and one-half of one warrant. Each whole warrant entitles the holder thereof to purchase one share of our common stock at a price of $11.50 per share, subject to adjustment as described in this prospectus, and only whole warrants are exercisable. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination and 12 months from the closing of this offering, and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation, as described in this prospectus. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. | https://stockhouse.com/companies/quote?symbol=ENSC | Undervalued | 0.0297 | 0.002 | NULL | NULL | NULL | NULL | NULL | NULL | ENSC | ENSCW | NULL | ENSC | ENSCW | NULL | 2026-02-04 12:00 AM | 0.63 | 0.63 | 0.53 | 0.5691 | 211,128 | 2026-02-04 12:00 AM | 0.0068 | 0.01 | 0.0068 | 0.010 | 50,000 | -6.659012629161877 | 177.78 | -10.93 | ||||||||||||
| 15149 | Bluerock Acquisition Corp. | SPAC | NULL | BLRK | BLRKW | NULL | 1 wt:1 sh | 2027-12-11 | 11.5000 | US | 2,081,532 | NULL | None | 212-843-1601 | 27777 FRANKLIN ROAD, SUITE 900, SOUTHFIELD, MI, 48034 | Bluerock Acquisition Corp. is a blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination in any business or industry. |  |
NULL | Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as described herein. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The warrants will become exercisable 30 days after the completion of our initial business combination, and will expire five years after the completion of our initial business combination or earlier upon redemption or our liquidation, as described in more detail herein. Subject to the terms and conditions described in this prospectus, we may redeem the warrants for cash once the warrants become exercisable. The underwriters have a 45-day option from the date of this prospectus to purchase up to an additional 2,250,000 units to cover over-allotments, if any. | 0.3895 | 0.2301 | 2026-02-04 12:00 AM | 9.9 | 9.9 | 9.9 | 9.9000 | 1,392 | 2026-02-04 12:00 AM | 0.4155 | 0.4155 | 0.3895 | 0.390 | 269 | 0 | 69.27 | -1.60 | |||||||||||||||||||||||||||||||
| 13228 | SIM Acquisition Corp. I | SPAC | NULL | SIMA | SIMAW | NULL | NULL | 1 wt:1 sh | 2026-07-09 | 11.5000 | US | 2,014,982 | NULL | Nasdaq | 2039402657 | 78 SW 7TH STREET, SUITE 500, MIAMI, FL, 33130 | SIM Acquisition Corp. I is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination in any business or industry but expect to focus on companies in the healthcare industry. | |
NULL | Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as described herein. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The warrants will become exercisable 30 days after the completion of our initial business combination, and will expire five years after the completion of our initial business combination or earlier upon redemption or our liquidation, as described herein. The underwriters have a 45-day option from the date of this prospectus to purchase up to an additional 3,000,000 units to cover over-allotments, if any. | https://stockhouse.com/companies/quote?symbol=SIMA | Coming Soon | 0.4196 | 0.1014 | SIMA | SIMAW | NULL | 2026-02-04 12:00 AM | 10.68 | 10.68 | 10.68 | 10.6800 | 432 | 2026-02-04 12:00 AM | 0.422 | 0.44 | 0.4 | 0.420 | 929,006 | 0.3287928604978877 | 44.69 | -0.82 | |||||||||||||||||||||||||
| 9647 | New Nuvini | B2B, SAAS | B2B, SAAS | B2B, SAAS | NULL | NVNI | NVNIW | NULL | NULL | 1 wt:1 sh | 2028-10-02 | 11.5000 | US | 1,853,436 | NULL | NSDQ | (801) 220-0055 | 2750 E. COTTONWOOD PARKWAY, SUITE #500, COTTONWOOD HEIGHTS, UT, 84121 | -111.808183 | 40.632157 | We believe that it is possible to create a company whose sum of its parts results in the multiplication of its results. Not only financially, but also for the founders, teams, and clients. Through four strategic pillars, we help the founders of acquired companies to accelerate the growth of their SaaS startups, so that they can continue to grow their business. If your company’s ARR is between U$2 million and U$10 million per year and grows profitably, let’s talk to understand how we can go further together! |  |
Merger Completed on Monday, 10/02/2023 | Each unit has an offering price of $10.00 and consists of: one share of our Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment as described in this prospectus. Only whole warrants are exercisable. The warrants will become exercisable 30 days after the completion of our initial business combination, and will expire five years after the completion of our initial business combination or earlier upon redemption or our liquidation (the “warrant expiration date”), as described in this prospectus. Subject to the terms and conditions described in this prospectus, we may redeem the warrants for cash once the warrants become exercisable. | https://stockhouse.com/companies/quote?symbol=NVNI | Coming Soon | 0.2250 | 0.026 | NULL | NULL | NULL | NULL | NULL | NULL | MPRA | MPRAW | NULL | NVNI | NVNIW | NULL | 2026-02-04 12:00 AM | 1.57 | 1.64 | 1.47 | 1.5300 | 79,247 | 2026-02-04 12:00 AM | 0.0441 | 0.0575 | 0.04 | 0.058 | 2,132 | -5.55555555555556 | 43.03 | -9.97 | ||||||||||||
| 10033 | Psyence Biomedical Ltd. | BIOMED | Biomedical | BIOMEDICAL-Psyence Biomedical Ltd is developing clinical trials in the field of palliative care. Our clinical trial program is focused on assessing the safety and efficacy of psilocybin-assisted therapy for the treatment of adjustment disorder in people with terminal diagnoses in comparison to psychotherapy alone. Adjustment disorder is an emotional or behavioural reaction to a stressful event in one’s life. We have partnered with leading psychedelic contract research organisation Ingenu to design and deliver our first clinical trial in Australia. | NULL | PBM | PBMWW | NULL | NULL | 1 wt:1 sh | 2029-01-26 | 11.5000 | US | 1,849,475 | NULL | NSDQ | 27 83 294 3837 | 2201 BROADWAY, SUITE 705, OAKLAND, CA, 94612 | -122.2671082 | 37.8112144 | Newcourt Acquisition Corp is a newly incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. |  |
Merger Completed on Friday, 01/26/2024 | Each unit has an offering price of? $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of? $11.50 per share, subject to adjustment as provided herein. Only whole warrants are exercisable and will trade. | https://stockhouse.com/companies/quote?symbol=PBM | Coming Soon | 0.0379 | 0.01 | NULL | NULL | NULL | NULL | NULL | NULL | NCAC | NCACW | NULL | PBM | PBMWW | NULL | 2026-02-04 12:00 AM | 3.07 | 3.25 | 2.535 | 3.2400 | 198,689 | 2026-02-04 12:00 AM | 0.0159 | 0.0212 | 0.0159 | 0.021 | 5,814 | 4.854368932038847 | 32.50 | -8.26 | ||||||||||||
| 8834 | Valens Semiconductor, Ltd. | SEMICONDUCTOR | Semiconductor | High Tech | NULL | VLN | VLN.WS | NULL | NULL | 2 wt:1 sh | 2026-09-30 | 11.5000 | US | 1,797,099 | NULL | NYSE | 6509952208 | 100 NORTH AVENUE, BOSTON, MA, 02210 | 34.8930354 | 32.1561974 | Valens is a leading provider of semiconductor products, pushing the boundaries of connectivity by enabling long-reach, high-speed video and data transmission for the audio-video and automotive industries. Valens’ Emmy® award-winning HDBaseT technology is the leading standard in the professional audio-video market with tens of millions of Valens’ chipsets integrated into thousands of HDBaseT-enabled products. Valens Automotive is a key enabler of the evolution of autonomous driving, providing chipsets that are on the road in vehicles around the world. The underlying technology has been selected to become the basis for MIPI A-PHY, the global standard for automotive connectivity. Founded in 2006, Valens is based in Hod Hasharon, Israel, with offices in the US, Europe and Asia. For more information: www.valens.com. |  |
Merger Completed on Thursday, 09/30/2021 | Each unit that we are offering has a price of $10.00 and consists of one share of common stock, par value $0.0001, and one warrant, as described in more detail in this prospectus. We refer to the warrants included in the units as “warrants” or the “public warrants”. Each warrant entitles the holder thereof to purchase one half (1/2) of one share of common stock at a price of $11.50 per whole share, subject to adjustment as described in the prospectus. We will not issue fractional shares. As a result, you must exercise warrants in multiples of two warrants, at a price of $11.50 per full share, subject to adjustment as described in this prospectus, to validly exercise your warrants. Each warrant will become exercisable on the later of one year after the effective date of this registration statement or the consummation of an initial business combination, and will expire five years from the consummation of a Business Combination, or earlier upon redemption. If we are unable to consummate a business combination within 18 months from the closing of this offering, we will redeem 100% of the public shares using the funds in the trust account described below. In such event, the public warrants will expire and be worthless. | https://stockhouse.com/companies/quote?symbol=VLN | Undervalued | 0.1599 | 0.025 | NULL | NULL | NULL | NULL | NULL | NULL | VLN | VLN-WT | NULL | VLN | VLN/W | NULL | 2026-02-04 12:00 AM | 1.62 | 1.63 | 1.49 | 1.5400 | 954,648 | 2026-02-04 12:00 AM | 0.0672 | 0.08 | 0.0671 | 0.080 | 2,612 | -3.7500000000000036 | 31.15 | -19.92 | ||||||||||||
| 8740 | Holley Intermediate Holdings Inc. (“Holley”) | CONSUMER | Consumer | Consumer goods and services sector | NULL | HLLY | HLLY.WS | NULL | NULL | 1 wt:1 sh | 2026-07-16 | 11.5000 | US | 1,822,928 | NULL | NYSE | 2124971400 | 2445 NASHVILLE ROAD, SUITE B1, BOWLING GREEN, KY, 42101 | -86.465776 | 36.981633 | Holley is a leading designer, marketer, and manufacturer of high-performance products for car and truck enthusiasts. Holley offers the largest portfolio of iconic brands that deliver innovation and inspiration to a large and diverse community of millions of avid automotive enthusiasts who are passionate about the performance and personalization of their classic and modern cars. Holley has disrupted the performance category by putting the enthusiast consumer first, developing innovative new products, and building a robust M&A process that has added meaningful scale and diversity to its platform. |  |
Merger Completed on Friday, 07/16/2021 | Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to the adjustments, terms and limitations as described herein. The underwriters have a 45-day option from the date of this prospectus to purchase up to 3,750,000 additional units to cover over-allotments, if any. | https://stockhouse.com/companies/quote?symbol=HLLY | Coming Soon | 0.2490 | 0.0342 | NULL | NULL | NULL | NULL | NULL | NULL | HLLY | HLLY-WT | NULL | HLLY | HLLY/W | NULL | 2026-02-04 12:00 AM | 4.21 | 4.265 | 4.15 | 4.1600 | 766,181 | 2026-02-04 12:00 AM | 0.13 | 0.1302 | 0.13 | 0.130 | 700 | 0 | 30.07 | -7.34 | ||||||||||||
| 15546 | LION ONE METALS LTD | LOMWF | US | 1,509,397 | NULL | OTC | (604) 998-1250 | 311 WEST 1ST STREET, VANCOUVER, A1, V7M 1B5 |  |
0.1120 | 0.0775 | 2026-02-04 12:00 AM | 0.112 | 0.112 | 0.112 | 0.112 | 5,000 | 26.84 |
ID:
Company:
sector:
industry:
industry_subclass:
usSymbol:
commonSymbol:
Warrant:
rtSymbol:
cusip:
filingLink:
underlyingDocument:
warrantTerms:
expiry:
exercise:
country:
sec_cik:
sedar_ref:
exchange:
phone:
address:
longitude:
latitude:
description:
targetCountry:
logo_src:
notes:
warrant_clause:
insiders:
commonChart:
RATING:
Website:
warrantATH:
warrantATL:
project:
property:
prop_lon:
prop_lat:
prop_type:
prop_details:
front_adj_common:
front_adj_wt:
front_adj_rt:
chart_c:
chart_w:
chart_r:
cdate:
copen:
chigh:
clow:
cclose:
cvolume:
wdate:
wopen:
whigh:
wlow:
Wt Close:
Wt Volume:
rdate:
ropen:
rhigh:
rlow:
rclose:
rvolume:
cpctchg:
Wt PCT CHG:
rpctchg:
Intrinsic:
Losers
| ID | Company | sector | industry | industry_subclass | usSymbol | commonSymbol | Warrant | rtSymbol | cusip | filingLink | underlyingDocument | warrantTerms | expiry | exercise | country | sec_cik | sedar_ref | exchange | phone | address | longitude | latitude | description | targetCountry | logo_src | notes | warrant_clause | insiders | commonChart | RATING | website | warrantATH | warrantATL | project | property | prop_lon | prop_lat | prop_type | prop_details | front_adj_common | front_adj_wt | front_adj_rt | chart_c | chart_w | chart_r | cdate | copen | chigh | clow | cclose | cvolume | wdate | wopen | whigh | wlow | Wt Close | Wt Volume | rdate | ropen | rhigh | rlow | rclose | rvolume | cpctchg | Wt PCT CHG | rpctchg | Intrinsic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9447 | Ocean Biomedical | BIOMED | BIOMED | BioMedical - Medical Discoveries | NULL | OCEA | OCEAW | NULL | NULL | 1 wt:1 sh | 2027-02-13 | 11.5000 | US | 1,869,974 | NULL | None | (646) 908-2658 | 515 MADISON AVE SUITE 8078, NEW YORK, NY, 10022 | -73.974119 | 40.759773 | Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. | |
Merger Completed on Sunday, 02/13/2022 | Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one-half of one redeemable warrant as described in more detail in this prospectus. Only whole warrants are exercisable. Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment as described herein. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. | https://stockhouse.com/companies/quote?symbol=OCEA | Coming Soon | 0.0350 | 0.000001 | NULL | NULL | NULL | NULL | NULL | NULL | OCEA | OCEAW | NULL | OCEA | OCEAW | NULL | 2026-02-04 12:00 AM | 0.0017 | 0.0017 | 0.0017 | 0.0017 | 195 | 2026-02-04 12:00 AM | 0.000001 | 0.0005 | 0.000001 | 0.000 | 1,000 | 69.99999999999999 | -99.88 | -11.50 | ||||||||||||
| 9225 | SpringBig | CANNABIS | Cannabis | Cannabis | NULL | SBIG | SBIGW | NULL | NULL | 1 wt:1 sh | 2027-06-14 | 11.5000 | US | 1,801,602 | NULL | OTC | (800) 772-9172 | 621 NW 53RD ST, SUITE 260, BOCA RATON, FL, 33487 | -73.7069234 | 42.7137923 | Tuatara Capital Acquisition Corporation is a newly incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. While we may pursue a business combination target in any business, industry or geographical location, we intend to focus our search for businesses in the cannabis industry that are compliant with all applicable laws and regulations within the jurisdictions in which they are located or operate and, in particular, we will not invest in, or consummate a business combination with, a target business that we determine has been operating, or whose business plan is to operate, in violation of U.S. federal laws, including the U.S. Controlled Substances Act. |  |
Merger Completed on Tuesday, 06/14/2022 | Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as provided herein, and only whole warrants are exercisable. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination and 12 months from the closing of this offering, and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation, as described in this prospectus. | https://stockhouse.com/companies/quote?symbol=SBIG | Coming Soon | 0.0059 | 0.0005 | NULL | NULL | NULL | NULL | NULL | NULL | SBIG | SBIGW | NULL | SBIG | SBIGW | NULL | 2026-02-04 12:00 AM | 0.0098 | 0.0098 | 0.00875 | 0.0088 | 2,650 | 2026-02-04 12:00 AM | 0.0007 | 0.0007 | 0.0007 | 0.001 | 25,000 | 13.636363636363644 | -80.00 | -11.49 | ||||||||||||
| 5980 | Nuvation Bio Inc. | BIOPHARMA | Biopharma | Biopharmaceuticals-Cancer | NULL | NUVB | NUVB.WS | NULL | NULL | 1 wt:1 sh | 2026-02-10 | 11.5000 | US | 1,811,063 | NULL | NYSE | 332-208-6102 | 1500 BROADWAY, SUITE 1401, NEW YORK, NY, 10036 | -122.4033778 | 37.7816754 | Nuvation Bio is a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Our vision is to significantly change the practice of oncology by developing medicines that provide truly meaningful improvements in quality of life and survival for people with cancer. Our wholly-owned deep pipeline includes six differentiated and novel investigational oncology therapeutic candidates that target some of the most critical pathways that cancer cells use to grow. We were founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York and San Francisco. |  |
Merger Completed on Wednesday, 02/10/2021 | Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment as described in this prospectus, and only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination and 12 months from the closing of this offering, and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation, as described in this prospectus. Subject to the terms and conditions described in this prospectus, we may redeem the warrants once the warrants become exercisable. | https://stockhouse.com/companies/quote?symbol=NUVB | Coming Soon | 0.6200 | 0.0156 | NULL | NULL | NULL | NULL | NULL | NULL | NUVB | NUVB-WT | NULL | NUVB | NUVB/W | NULL | 2026-02-04 12:00 AM | 5.9 | 6.015 | 5.505 | 5.8600 | 7,231,726 | 2026-02-04 12:00 AM | 0.03 | 0.03 | 0.0154 | 0.016 | 30,412 | -0.6779661016949159 | -46.94 | -5.64 | ||||||||||||
| 13147 | Launch One Acquisition Corp. Warrant | SPAC | NULL | LPAA | LPAAW | NULL | NULL | 1 wt:1 sh | 2026-07-11 | 11.5000 | US | 2,015,502 | NULL | Nasdaq | 5106929600 | 180 GRAND AVENUE SUITE 1530, OAKLAND, CA, 94612 | Launch One Acquisition Corp.is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We may pursue an initial business combination in any business or industry. | |
NULL | Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as described herein. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The warrants will become exercisable 30 days after the completion of our initial business combination, and will expire five years after the completion of our initial business combination or earlier upon redemption or our liquidation, as described herein. The underwriters have a 45-day option from the date of this prospectus to purchase up to an additional 3,000,000 units to cover over-allotments, if any. | https://stockhouse.com/companies/quote?symbol=LPAA | Coming Soon | 0.3100 | 0.1101 | LPAA | LPAAW | NULL | 2026-02-04 12:00 AM | 10.7 | 10.7 | 10.64 | 10.6400 | 26,811 | 2026-02-04 12:00 AM | 0.15 | 0.15 | 0.1064 | 0.110 | 1,081,068 | 0 | -44.92 | -0.86 | |||||||||||||||||||||||||
| 5878 | Crown PropTech Acquisitions | TECHNOLOGY | SPAC | Technology - Real Estate | NULL | CPTK | CPTKW | NULL | NULL | 1 wt:1 sh | 2024-08-11 | 11.5000 | US | 1,827,899 | NULL | NYSE | 212-563-6400 | 28 WEST 25TH STREET, 6TH FLOOR, NEW YORK, NY, 10010 | 125.5421004 | 7.0488562 | Crown PropTech Acquisitions is a newly incorporated blank check company incorporated as a Cayman Islands exempted company and incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. |  |
Merger Pending as of Thursday, 07/03/2025 with Mkango Rare Earths and is expected to close on or around NULL | Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as described herein. Only whole warrants are exercisable. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination and 12 months from the closing of this offering, subject to further conditions described elsewhere in this prospectus, and will expire five years after the completion of our initial business combination or earlier upon redemption or our liquidation | https://stockhouse.com/companies/quote?symbol=CPTK | Coming Soon | 0.0900 | 0.000001 | NULL | NULL | NULL | NULL | NULL | NULL | CPTK | CPTK-WT | NULL | CPTK | CPTKW | NULL | 2024-02-09 12:00 AM | 10.67 | 10.78 | 10.67 | 10.7800 | 22,276 | 2026-02-04 12:00 AM | 0.0501 | 0.06 | 0.0501 | 0.050 | 29,062 | 0 | -44.33 | -0.72 | ||||||||||||
| 6196 | AMPLITECH GROUP, INC. | TECHNOLOGY MANUFACTURING, CONSULTING | Technology Manufacturing | Device manufacturing - 5G/6G, IoT, Satcom, Quantum Computing, Cyber Security, Blockchain Consulting & Engineering Services | NULL | AMPG | AMPGW | NULL | NULL | 1 wt:1 sh | 2026-02-17 | 7.0000 | US | 1,518,461 | NULL | Nasdaq | 631-521-7831 | 155 PLANT AVENUE, HAUPPAUGE, NY, 11788 | -73.096971 | 40.7792214 | AmpliTech Group, Inc. together with its subsidiary, Amplitech, Inc., a New York corporation “AmpliTech” or the “Company”), designs, engineers and assembles micro-wave component-based amplifiers that meet individual customer specifications. Our products consist of radio frequency (“RF”) amplifiers and related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including low noise amplifiers, medium power amplifiers, cryogenic amplifiers, and custom assembly designs for the aerospace, governmental, defense and commercial satellite markets. We also offer non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time plus material basis. |  |
Primarily produces wide band low noise amplifiers needed for RF signaling. Top 20 Global Producers. Large demand for 5G/6G and Satcom. Consulting and Engineering Services | Each Unit consists of one share of common stock, $0.001 par value per share, and one warrant (each, a “Warrant” and collectively, the “Warrants”) to purchase one share of common stock at an exercise price of $7.00 per share. The Units have no stand-alone rights and will not be certificated or issued as stand-alone securities. The shares of common stock and the Warrants comprising the Units are immediately separable and will be issued separately in this offering. Each Warrant offered hereby is immediately exercisable on the date of issuance and will expire five years from the date of issuance. | https://stockhouse.com/companies/quote?symbol=AMPG | Coming Soon | 0.8584 | 0.05 | NULL | NULL | NULL | NULL | NULL | NULL | AMPG | AMPGW | NULL | AMPG | AMPGW | NULL | 2026-02-04 12:00 AM | 3.1 | 3.1 | 2.7649 | 2.8500 | 1,161,740 | 2026-02-04 12:00 AM | 0.1111 | 0.1111 | 0.0734 | 0.087 | 11,549 | -7.766990291262128 | -42.10 | -4.15 | ||||||||||||
| 9221 | MSP Recovery, Inc. | HEALTHCARE, CONSUMER, TECHNOLOGY | Healthcare | Medicare, Medicaid, commercial, and secondary payer reimbursement recovery | NULL | MSPR | MSPRW | NULL | NULL | 1 wt:1 sh | 2027-05-24 | 11.5000 | US | 1,802,450 | NULL | OTC | 305.614.2222 | 3150 SW 38TH AVENUE, SUITE 1100, MIAMI, FL, 33146 | -80.1916604 | 25.8153609 | Lionheart Acquisition Corp II operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. | |
Merger Completed on Tuesday, 05/24/2022 | Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment as described herein. Warrants may be exercised only for a whole number of shares of Class A common stock. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination or 12 months from the closing of this offering, and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation, as described in this prospectus. | https://stockhouse.com/companies/quote?symbol=MSPR | Coming Soon | 0.0047 | 0.0002 | NULL | NULL | NULL | NULL | NULL | NULL | LIFW | LIFWZ | NULL | MSPR | MSPRW | NULL | 2026-02-04 12:00 AM | 0.045 | 0.05 | 0.031 | 0.0400 | 106,259 | 2026-02-04 12:00 AM | 0.0005 | 0.0006 | 0.0003 | 0.000 | 3,283,579 | -18.367346938775512 | -40.00 | -11.46 | ||||||||||||
| 15506 | AYR WELLNESS INC | AYWWF | US | 1,847,462 | NULL | OTC | 949-574-3860 | 199 BAY STREET, SUITE 5300, TORONTO, M5L 1B9 |  |
0.1120 | 0.0003 | 2026-02-04 12:00 AM | 0.0004 | 0.00065 | 0.0004 | 0.000 | 1,670 | -38.46 | |||||||||||||||||||||||||||||||||||||||||||||||||
| 9389 | NUBURU, Inc. | TECHNOLOGY | Technology | High Speed Technology | NULL | BURU | BURUW | NULL | NULL | 1 wt:1 sh | 2027-12-27 | 11.5000 | US | 1,814,215 | NULL | NYSE | (303) 780-7389 | 44 COOK STREET, SUITE 100, DENVER, CO, 80206 | -118.3573069 | 34.0988265 | NUBURU® is leading the transformation to a world of high-speed, high quality metal machining and processing. NUBURU ground-breaking blue laser technology has defined a new class of high-power, high-performance blue lasers, starting with the standard AO laser and the high-brightness BL™ series lasers, which each enable radical gains in speed and quality for metal processing. |  |
Merger Completed on Tuesday, 12/27/2022 | Each unit has an offering price of $10.00 and consists of one share of our Class A common stock and one-half of one warrant. Each whole warrant entitles the holder thereof to purchase one share of our Class A common stock at a price of $11.50 per share, subject to adjustment as described in this prospectus, and only whole warrants are exercisable. The warrants will become exercisable on the later of 30 days after the completion of our initial business combination or twelve months from the closing of this offering, and will expire five years after the completion of our initial business combination or earlier upon redemption or liquidation, as described in this prospectus. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. | https://stockhouse.com/companies/quote?symbol=BURU | Undervalued | 0.2054 | 0.0045 | NULL | NULL | NULL | NULL | NULL | NULL | BURU | BURU-WT | NULL | BURU | BURUW | NULL | 2026-02-04 12:00 AM | 0.17 | 0.1718 | 0.1497 | 0.1542 | 53,647,714 | 2026-02-04 12:00 AM | 0.025 | 0.033 | 0.0201 | 0.022 | 71,507 | -12.13675213675213 | -36.92 | -11.35 | ||||||||||||
| 9633 | Lifezone Metals | RENEWABLE | Energy | Clean/ Rrenewable energy (energy transition) | NULL | LZM | LZM.WS | NULL | NULL | 1 wt:1 sh | 2028-07-06 | 11.5000 | US | 1,852,940 | NULL | NYSE | 7133374075 | 1021 MAIN STREET, SUITE 1960, HOUSTON, TX, 77002 | -95.3650056 | 29.7567008 | GoGreen Investments Corporation is a newly incorporated blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which we refer to throughout this prospectus as our initial business combination. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. |  |
Merger Completed on Thursday, 07/06/2023 | Each unit has an offering price of $10.00 and consists of one of our Class A ordinary shares and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as provided herein. Only whole warrants are exercisable and will trade. | https://stockhouse.com/companies/quote?symbol=LZM | Coming Soon | 0.8387 | 0.1504 | NULL | NULL | NULL | NULL | NULL | NULL | GOGN | GOGN-WT | NULL | LZM | LZM/W | NULL | 2026-02-04 12:00 AM | 5.39 | 5.39 | 4.94 | 5.0700 | 282,378 | 2026-02-04 12:00 AM | 0.525 | 0.525 | 0.525 | 0.525 | 1,506 | -4.6992481203007515 | -34.24 | -6.43 |
ID:
Company:
sector:
industry:
industry_subclass:
usSymbol:
commonSymbol:
Warrant:
rtSymbol:
cusip:
filingLink:
underlyingDocument:
warrantTerms:
expiry:
exercise:
country:
sec_cik:
sedar_ref:
exchange:
phone:
address:
longitude:
latitude:
description:
targetCountry:
logo_src:
notes:
warrant_clause:
insiders:
commonChart:
RATING:
website:
warrantATH:
warrantATL:
project:
property:
prop_lon:
prop_lat:
prop_type:
prop_details:
front_adj_common:
front_adj_wt:
front_adj_rt:
chart_c:
chart_w:
chart_r:
cdate:
copen:
chigh:
clow:
cclose:
cvolume:
wdate:
wopen:
whigh:
wlow:
Wt Close:
Wt Volume:
rdate:
ropen:
rhigh:
rlow:
rclose:
rvolume:
cpctchg:
Wt PCT CHG:
rpctchg:
Intrinsic: